Understanding RNA-U6SN947: A Potential Drug Target and Biomarker

Target Name: RNU6-947P

NCBI ID: G106479985

RNU6-947P

Other Name(s): RNA, U6 small nuclear 947, pseudogene

Understanding RNA-U6SN947: A Potential Drug Target and Biomarker

RNA-U6 small nuclear 947 (RNA, U6SN947, pseudogene) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and expression pattern have made it an attractive target for researchers to study.

RNA-U6SN947 is a small non-coding RNA molecule that is located within the nucleus of the human chromosome 6. It is characterized by a single open reading frame (ORF) that consists of 94 amino acid residues. The ORF has a unique structure, with a conserved core and a unique 5' end that is not found in any other known RNA molecule.

RNA-U6SN947 has been expressed in various cell types, including human embryonic stem cells, neurons, and tissues. Its expression level has been shown to be different in different cell types, which suggests that it may play a role in cell-specific processes. The expression of RNA-U6SN947 has also been associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the reasons why RNA-U6SN947 has drawn attention is its potential as a drug target. The unique structure of the ORF and its expression in different cell types make it an attractive target for small molecules, antibodies, or other therapeutic agents that can interact with it.

RNA-U6SN947 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been shown to be involved in the regulation of cell cycle progression, cell survival, and neurotransmitter signaling. RNA-U6SN947 has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its potential as a drug target, RNA-U6SN947 has also been shown to be a potential biomarker. Its unique expression pattern and the fact that it is not found in any other known RNA molecule make it an attractive target for diagnostic tools, such as qRT-PCR, RNA sequencing, or stable isotope labeling with amino acids in cell culture (SILAC). RNA-U6SN947 has also been shown to be expressed in various biological fluids, including blood, saliva, and urine, which suggests that it may be a useful biomarker for various diseases.

In conclusion, RNA-U6SN947 is a unique and promising molecule that has drawn attention for its potential as a drug target and biomarker. Its unique structure and expression pattern make it an attractive target for small molecules, antibodies, or other therapeutic agents that can interact with it. Further research is needed to fully understand its role in cellular processes and its potential as a drug and biomarker.

Protein Name: RNA, U6 Small Nuclear 947, Pseudogene

The "RNU6-947P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNU6-947P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets